Irish MedTech pioneer Tympany Medical has launched a €600,000 crowdfunding campaign via Crowdcube under the Employment and Investment Incentive Scheme (EIIS), offering a 50% tax rebate for Irish taxpayers. The campaign invites both seasoned and first-time investors to back innovation that improves surgical outcomes while supporting a sustainable healthcare future.
At the centre of Tympany Medical’s growth is Solascope, a next-generation endoscope platform designed for the 20 million procedures annually requiring endoscopic visualisation. Starting with ENT surgery, Solascope combines a variable-angle camera, integrated cleaning, and a hybrid single-use design: a sterile, disposable endoscope paired with a reusable handle. This reduces medical waste, improves patient safety, and enhances surgeon ergonomics, a clear step forward for modern surgery.
(L-R) Rory O'Callaghan, Liz McGloughlin and Michael Gilmore.
Michael Gilmore, recently appointed as CEO brings business and engineering expertise, to complement the founding team of Dr. Liz McGloughlin and Rory O'Callaghan. In 2024, industry veteran Charlie Wilhelm, former COO of Karl Storz USA, Chairperson, bringing over 30 years of endoscopic experience and is a key driving force within the business.
With 15 employees and a scalable roadmap, Tympany Medical is poised for commercial acceleration, targeting regulatory approvals, global partnerships, and early market deployment. The €600,000 Crowdcube round forms part of a larger €4.5 million fundraising strategy to refine the product and expand internationally.
Tympany Medical offers investors the chance to back a homegrown, mission-driven company redefining surgical care. This is not just an investment in a device, it’s a stake in smarter, safer, and more sustainable surgery.
Invest via Crowdcube with 50% EIIS relief:
www.crowdcube.eu/companies/tympany-medical/pitches/lGYWXb
